Cardiac Ablation Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Cardiac Ablation Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update


Summary

GlobalData's Medical Devices sector report, “Cardiac Ablation Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Cardiac Ablation Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Cardiac Ablation Devices are devices that use radiofrequency energy to destroy cardiac tissues which propagate incorrect electrical signals to cause an abnormal heart rhythm.

Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Cardiac Ablation Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Cardiac Ablation Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Cardiac Ablation Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Cardiac Ablation Devices Overview
4 Products under Development
4.1 Cardiac Ablation Devices - Pipeline Products by Stage of Development
4.2 Cardiac Ablation Devices - Pipeline Products by Territory
4.3 Cardiac Ablation Devices - Pipeline Products by Regulatory Path
4.4 Cardiac Ablation Devices - Pipeline Products by Estimated Approval Date
4.5 Cardiac Ablation Devices - Ongoing Clinical Trials
5 Cardiac Ablation Devices - Pipeline Products under Development by Companies
5.1 Cardiac Ablation Devices Companies - Pipeline Products by Stage of Development
5.2 zeCardiac Ablation Devices – Companies Pipeline Products by Stage of Development
6 Cardiac Ablation Devices Companies and Product Overview
6.1 Abbott Medical Company Overview
6.1.1 Abbott Medical Pipeline Products & Ongoing Clinical Trials Overview
6.2 AblaCor Medical Corporation Company Overview
6.2.1 AblaCor Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
6.3 AccuPulse Medical Technology Co Ltd Company Overview
6.3.1 AccuPulse Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.4 Acutus Medical Inc Company Overview
6.4.1 Acutus Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.5 Adagio Medical Inc. Company Overview
6.5.1 Adagio Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
6.6 Affera Inc Company Overview
6.6.1 Affera Inc Pipeline Products & Ongoing Clinical Trials Overview
6.7 AFreeze GmbH Company Overview
6.7.1 AFreeze GmbH Pipeline Products & Ongoing Clinical Trials Overview
6.8 AngioDynamics Inc Company Overview
6.8.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
6.9 APT Medical Inc Company Overview
6.9.1 APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.1 Arga Medtech SA Company Overview
6.10.1 Arga Medtech SA Pipeline Products & Ongoing Clinical Trials Overview
6.11 Atrian Medical Ltd Company Overview
6.11.1 Atrian Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.12 AtriCure Inc Company Overview
6.12.1 AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview
6.13 Axon Therapies Inc Company Overview
6.13.1 Axon Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview
6.14 Baylis Medical Company Inc Company Overview
6.14.1 Baylis Medical Company Inc Pipeline Products & Ongoing Clinical Trials Overview
6.15 Biosense Webster Inc Company Overview
6.15.1 Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview
6.16 Corfigo Inc Company Overview
6.16.1 Corfigo Inc Pipeline Products & Ongoing Clinical Trials Overview
6.17 Coridea, LLC Company Overview
6.17.1 Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview
6.18 CPSI Biotech Company Overview
6.18.1 CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview
6.19 Cryofocus Medtech Shanghai Co Ltd Company Overview
6.19.1 Cryofocus Medtech Shanghai Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.2 CyberHeart Inc Company Overview
6.20.1 CyberHeart Inc Pipeline Products & Ongoing Clinical Trials Overview
6.21 ElectroPhysiology Frontiers S.p.A. Company Overview
6.21.1 ElectroPhysiology Frontiers S.p.A. Pipeline Products & Ongoing Clinical Trials Overview
6.22 Epiendoaf Inc Company Overview
6.22.1 Epiendoaf Inc Pipeline Products & Ongoing Clinical Trials Overview
6.23 Field Medical Inc Company Overview
6.23.1 Field Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.24 Galaxy Medical Products Inc Company Overview
6.24.1 Galaxy Medical Products Inc Pipeline Products & Ongoing Clinical Trials Overview
6.25 Hadassah Medical Center Company Overview
6.25.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview
6.26 Hangzhou Nuocheng Medical Technology Co Ltd Company Overview
6.26.1 Hangzhou Nuocheng Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.27 Hangzhou Nuomao Medical Technology Co Ltd Company Overview
6.27.1 Hangzhou Nuomao Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.28 Helical Solutions, Inc. (Inactive) Company Overview
6.28.1 Helical Solutions, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
6.29 Huifeng Biotechnology (Shanghai) Co Ltd Company Overview
6.29.1 Huifeng Biotechnology (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.3 Insight Lifetech Co Ltd Company Overview
6.30.1 Insight Lifetech Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.31 Johns Hopkins University Company Overview
6.31.1 Johns Hopkins University Pipeline Products & Ongoing Clinical Trials Overview
6.32 Kardium Inc Company Overview
6.32.1 Kardium Inc Pipeline Products & Ongoing Clinical Trials Overview
6.33 LuxCath, LLC Company Overview
6.33.1 LuxCath, LLC Pipeline Products & Ongoing Clinical Trials Overview
6.34 LuxMed Systems Inc Company Overview
6.34.1 LuxMed Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
6.35 Medtronic Plc Company Overview
6.35.1 Medtronic Plc Pipeline Products & Ongoing Clinical Trials Overview
6.36 National Science and Technology Development Agency Company Overview
6.36.1 National Science and Technology Development Agency Pipeline Products & Ongoing Clinical Trials Overview
6.37 Northwestern University Company Overview
6.37.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
6.38 Pavmed Inc Company Overview
6.38.1 Pavmed Inc Pipeline Products & Ongoing Clinical Trials Overview
6.39 Pulse Biosciences Inc Company Overview
6.39.1 Pulse Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
6.4 Shanghai Antec Medical Technology Co Ltd Company Overview
6.40.1 Shanghai Antec Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.41 Shanghai Hantong Medical Technology Co Ltd Company Overview
6.41.1 Shanghai Hantong Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.42 Shanghai HeartCare Medical Technology Co Ltd Company Overview
6.42.1 Shanghai HeartCare Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.43 Shanghai Keku Medical Technology Co Ltd Company Overview
6.43.1 Shanghai Keku Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.44 Shanghai Ruidao Medical Technology Co Ltd Company Overview
6.44.1 Shanghai Ruidao Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.45 Shanghai Weiqi Medical Equipment Co Ltd Company Overview
6.45.1 Shanghai Weiqi Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.46 Shanghai Xuanyu Medical Equipment Co Ltd Company Overview
6.46.1 Shanghai Xuanyu Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.47 Shenzhen Huitai Medical Equipment Co Ltd Company Overview
6.47.1 Shenzhen Huitai Medical Equipment Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.48 Shenzhen Maiwei Medical Technology Co Ltd Company Overview
6.48.1 Shenzhen Maiwei Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.49 Sichuan Jinjiang Electronic Science and Technology Co Ltd Company Overview
6.49.1 Sichuan Jinjiang Electronic Science and Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.5 SIGT LLC Company Overview
6.50.1 SIGT LLC Pipeline Products & Ongoing Clinical Trials Overview
6.51 Suzhou Aikemai Medical Technology Co Ltd Company Overview
6.51.1 Suzhou Aikemai Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.52 Tau Pnu Medical Co., Ltd. Company Overview
6.52.1 Tau Pnu Medical Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
6.53 The Chaim Sheba Medical Center Company Overview
6.53.1 The Chaim Sheba Medical Center Pipeline Products & Ongoing Clinical Trials Overview
6.54 Thermedical Inc Company Overview
6.54.1 Thermedical Inc Pipeline Products & Ongoing Clinical Trials Overview
6.55 Tianjin Intelligent Health Medical Co Ltd Company Overview
6.55.1 Tianjin Intelligent Health Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.56 Toray Medical Co Ltd Company Overview
6.56.1 Toray Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
6.57 Tufts Medical Center Company Overview
6.57.1 Tufts Medical Center Pipeline Products & Ongoing Clinical Trials Overview
6.58 University of California Los Angeles Company Overview
6.58.1 University of California Lovs Angeles Pipeline Products & Ongoing Clinical Trials Overview
6.59 University of Chicago Company Overview
6.59.1 University of Chicago Pipeline Products & Ongoing Clinical Trials Overview
6.6 University of Iowa Company Overview
6.60.1 University of Iowa Pipeline Products & Ongoing Clinical Trials Overview
6.61 Varian Medical Systems Inc Company Overview
6.61.1 Varian Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
6.62 Virginia Polytechnic Institute and State University Company Overview
6.62.1 Virginia Polytechnic Institute and State University Pipeline Products & Ongoing Clinical Trials Overview
6.63 VytronUS Inc (Inactive) Company Overview
6.63.1 VytronUS Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
7 Cardiac Ablation Devices- Recent Developments
7.1 Mar 14, 2024: Methodist Le Bonheur Healthcare first in Tennessee to offer Paradigm-Shifting Technology for AFib patients
7.2 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference
7.3 Mar 07, 2024: Overlake First in Pacific Northwest to Treat Atrial Fibrillation With New FDA-Approved Pulsed Field Ablation
7.4 Mar 01, 2024: Biosense Webster secures CE mark for Varipulse PFA system
7.5 Mar 01, 2024: SMH Physicians Using Break-Through Device to Treat Patients with AFib
7.6 Mar 01, 2024: WRH Electrophysiology Performs Innovative Procedure
7.7 Feb 28, 2024: Catheter Precision Announces the First Use of VIVO With a Pediatric Patient in Turkey
7.8 Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company
7.9 Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering
7.1 Feb 19, 2024: Boston Scientific Appoints Madan Krishnan to Lead India Subcontinent
7.11 Feb 14, 2024: Farapulse Obtains Pre-Market Approval (PMA) for FARAPULSE Pulsed Field Ablation (PFA) System
7.12 Feb 14, 2024: Pulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for Initial Patients treated in the CellFX nsPFA 360° Cardiac Catheter First-in-Human Feasibility Study
7.13 Feb 08, 2024: Biosense Webster Supports Collaborative Studies That Aim to Expand Knowledge in Pulsed Field Ablation
7.14 Feb 06, 2024: J&J unveils Varipulse data at AF Symposium
7.15 Feb 02, 2024: Biosense Webster Presents Late-Breaking Data from inspIRE and admIRE Clinical Trials at AF Symposium
7.16 Jan 31, 2024: Boston Scientific Receives FDA Approval for FARAPULSE Pulsed Field Ablation System
7.17 Jan 31, 2024: Pulse Biosciences Announces Preliminary Findings from Its CellFX nsPFA 360 Cardiac Catheter First-in-Human Feasibility Study to Be Featured in Podium Presentation at the AF Symposium
7.18 Jan 31, 2024: Boston Scientific Announces Results for Fourth Quarter and Full Year 2023
7.19 Jan 18, 2024: Abbott Announces First Global Procedures in a Clinical Trial of its Volt Pulsed Field Ablation System to Treat Patients with Abnormal Heart Rhythms
7.2 Jan 09, 2024: Biosense Webster Announces Regulatory Approval of VARIPULSE Pulsed Field Ablation (PFA) Platform in Japan
7.21 Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results
7.22 Jan 05, 2024: AngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance
7.23 Dec 28, 2023: Boston Scientific Initiates Avant Guard Clinical Trial to Evaluate Farapulse Pulsed Field Ablation System as First-Line Treatment for Persistent Atrial Fibrillation
7.24 Dec 21, 2023: Pulse Biosciences concludes procedures with cardiac catheter in study
7.25 Dec 14, 2023: Medtronic obtains US FDA approval for PulseSelect PFA system
7.26 Dec 13, 2023: Medtronic creates history with FDA approval of its novel PulseSelect Pulsed Field Ablation System to treat atrial fibrillation
7.27 Nov 21, 2023: Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous Electrode
7.28 Nov 20, 2023: Catheter Precision's (VTAK) First Successful VIVO Cases Completed in Croatia Sets Stage for Expansion into South-Eastern Europe
7.29 Oct 26, 2023: Boston Scientific Announces Results for Third Quarter 2023
7.3 Oct 10, 2023: Thermedical Awarded $3 Million NIH Grant to Study Promising Treatment for Ventricular Tachycardia, a Leading Cause of Sudden Cardiac Death
7.31 Oct 08, 2023: Late-Breaking Data Confirms Safety of Axon Therapies' Innovative Heart Failure Procedure and Identifies Patients Most Likely to Benefit from SAVM Therapy
7.32 Oct 04, 2023: Stereotaxis Robotic Technology to be Featured during 7th Annual Meeting of the Society for Cardiac Robotic Navigation
7.33 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business
7.34 Oct 02, 2023: Pulse Biosciences and Cardionxt to Collaborate on nsPFA First-In-Human Study
7.35 Sep 29, 2023: Pulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™) Circumferential Catheter System to be Featured in a Presentation at the Global EP Summit
7.36 Sep 27, 2023: Pulse Biosciences’ First Study in a Surgical Application of Nanosecond Pulsed Field Ablation (nsPFA) Technology to be Featured in Two Poster Presentations at the American Thyroid Association Annual Meeting
7.37 Sep 19, 2023: Canadian First - Abbott's TactiFlex Ablation Catheter Used to Treat AFib
7.38 Sep 18, 2023: Biosense Webster Begins Evaluation of Large-tip Focal Pulsed Field Ablation Catheter in Omny-IRE Clinical Trial in Europe
7.39 Aug 27, 2023: ADVENT Study of the FARAPULSE Pulsed Field Ablation System Meets Primary Efficacy and Safety Endpoints
7.4 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair
7.41 Aug 09, 2023: FDA grants approval for Boston Scientific’s cryoablation system
7.42 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024
7.43 Jul 24, 2023: Ra Medical System’s Electrophysiology Division Has Increased Demand for Its Non-invasive Mapping System
7.44 Jul 19, 2023: Boston Scientific lays off 52 workers as it closes another Silicon Valley facility
7.45 May 31, 2023: Kardium announces first US procedures in PULSAR study of Globe Pulsed Field System
7.46 May 22, 2023: Abbott gets FDA nod for TactiFlex Ablation Catheter to treat AFib
7.47 May 20, 2023: Data at Heart Rhythm 2023 highlight key Boston Scientific therapies
7.48 May 19, 2023: Varian announces first participant treated in RADIATE-VT clinical trial of cardiac radioablation for patients with Refractory Ventricular Tachycardia
7.49 May 19, 2023: Biosense Webster presents new data from pulsed field ablation investigational studies at Heart Rhythm 2023
7.5 May 19, 2023: Medtronic PulseSelect Pulsed Field Ablation System results in low Atrial arrhythmia burden for AFib patients
7.51 May 18, 2023: Pulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA) technology to be featured in several presentations at The Heart Rhythm 2023 Annual Meeting
7.52 May 18, 2023: Pre-clinical Pulsed-Field Ablation (PFA) Using a Single-Shot Circular Linear Ablation Catheter for PV Isolation
7.53 May 11, 2023: Medtronic to announce financial results for its fourth quarter and full fiscal year 2023
7.54 May 03, 2023: Adagio Medical announces completion of enrollment in Cryocure-VT trial, maps the pathway to CE-Mark of vCLAS VT ablation catheter
7.55 Apr 17, 2023: Ra Medical electrophysiology division is participating in EHRA Congress
7.56 Apr 12, 2023: Medtronic has a layoff in California
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Cardiac Ablation Devices - Pipeline Products by Stage of Development
Table 2: Cardiac Ablation Devices - Pipeline Products by Territory
Table 3: Cardiac Ablation Devices - Pipeline Products by Regulatory Path
Table 4: Cardiac Ablation Devices - Pipeline Products by Estimated Approval Date
Table 5: Cardiac Ablation Devices - Ongoing Clinical Trials
Table 6: Cardiac Ablation Devices Companies - Pipeline Products by Stage of Development
Table 7: Cardiac Ablation Devices – Companies Pipeline Products by Stage of Development
Table 8: Abbott Medical Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Volt Pulsed Field Ablation System - Product Status
Table 10: Volt Pulsed Field Ablation System - Product Description
Table 11: Abbott Medical - Ongoing Clinical Trials Overview
Table 12: Volt Pulsed Field Ablation System - A Pre-market, Multi-centered Clinical Study to Evaluate the Safety and Effectiveness of Volt Pulsed Field Ablation System
Table 13: AblaCor Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 14: AutoBlator - Product Status
Table 15: AutoBlator - Product Description
Table 16: CircumBlator AF Catheter Ablation System - Product Status
Table 17: CircumBlator AF Catheter Ablation System - Product Description
Table 18: AccuPulse Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 19: PFA Pulsed Electric Field Ablation System - Product Status
Table 20: PFA Pulsed Electric Field Ablation System - Product Description
Table 21: AccuPulse Medical Technology Co Ltd - Ongoing Clinical Trials Overview
Table 22: PFA Pulsed Electric Field Ablation System - Feasibility and Safety Evaluation of the Pulsed Electric Field Ablation System on Patients with Chronic Bronchitis
Table 23: Acutus Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: AcQBlate Force Sensing Ablation Catheter - Product Status
Table 25: AcQBlate Force Sensing Ablation Catheter - Product Description
Table 26: Adagio Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 27: iCLAS System - Product Status
Table 28: iCLAS System - Product Description
Table 29: PFCA (Pulsed Field Cryoablation) System - Product Status
Table 30: PFCA (Pulsed Field Cryoablation) System - Product Description
Table 31: Adagio Medical Inc. - Ongoing Clinical Trials Overview
Table 32: iCLAS System - A First-in-human Study of Pulsed Field Cryoablation for the Treatment of Patients with Atrial Fibrillation
Table 33: iCLAS System - Cryoablation for Monomorphic Ventricular Tachycardia
Table 34: iCLAS System - Cryoablation for Monomorphic Ventricular Tachycardia Early Feasibility Study (EFS)
Table 35: iCLAS System - iCLAS Cryoablation System Post-Market Clinical Follow-up (PMCF) Study
Table 36: iCLAS System - iCLAS for Persistent Atrial Fibrillation
Table 37: iCLAS System - PARALELL - Pulsed Field Ablation and Pulsed Field CRyoAbLation in PErsistent AtriaL FibrilLation
Table 38: PFCA (Pulsed Field Cryoablation) System - PARALELL - Pulsed Field Ablation and Pulsed Field CRyoAbLation in PErsistent AtriaL FibrilLation
Table 39: Affera Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 40: Affera Mapping and Ablation System - Product Status
Table 41: Affera Mapping and Ablation System - Product Description
Table 42: HexaGEN Ablation System - Product Status
Table 43: HexaGEN Ablation System - Product Description
Table 44: Sphere9 Catheter - Product Status
Table 45: Sphere9 Catheter - Product Description
Table 46: SpherePVI - Product Status
Table 47: SpherePVI - Product Description
Table 48: Affera Inc - Ongoing Clinical Trials Overview
Table 49: Sphere9 Catheter - Study to Evaluate the Safety and Efficacy of Lattice Sphere Catheter to Reduce Complication Risk During Cardiac Ablation
Table 50: Affera Mapping and Ablation System - First-in-human Study Evaluating the Safety and Effectiveness of the SpherePVI Catheter and Affera System in Patients with Atrial Fibrillation
Table 51: Affera Mapping and Ablation System - The Affera Global Registry Is A Prospective, Global, Multi-center, Observational Post-Market Registry (PMR)
Table 52: Affera Mapping and Ablation System - Treatment of Persistent Atrial Fibrillation with the Sphere-9 Mapping and Ablation Catheter and the Affera Mapping and Ablation System
Table 53: SpherePVI - A Safety and Performance Assessment of the Affera SpherePVI Multi-Ablation System to Treat Paroxysmal Atrial Fibrillation
Table 54: SpherePVI - A Safety and Performance Assessment of the SpherePVI Catheter and the Affera Mapping and Ablation System to Treat Paroxysmal Atrial Fibrillation
Table 55: SpherePVI - First-in-human Study Evaluating the Safety and Effectiveness of the SpherePVI Catheter and Affera System in Patients with Atrial Fibrillation
Table 56: AFreeze GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 57: Tip-Catheter - Product Status
Table 58: Tip-Catheter - Product Description
Table 59: AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 60: Non-Thermal Vein Ablation Device - Product Status
Table 61: Non-Thermal Vein Ablation Device - Product Description
Table 62: APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 63: Pulse Ablation Generator - Product Status
Table 64: Pulse Ablation Generator - Product Description
Table 65: Ring Pulse Ablation Catheter - Product Status
Table 66: Ring Pulse Ablation Catheter - Product Description
Table 67: Arga Medtech SA Pipeline Products & Ongoing Clinical Trials Overview
Table 68: Coherent Sine-Burst Electroporation Ablation System - Product Status
Table 69: Coherent Sine-Burst Electroporation Ablation System - Product Description
Table 70: Non-Thermal Cardiac Ablation System - Product Status
Table 71: Non-Thermal Cardiac Ablation System - Product Description
Table 72: Arga Medtech SA - Ongoing Clinical Trials Overview
Table 73: Coherent Sine-Burst Electroporation Ablation System - An IDE Study Coherent Sine-Burst Pulsed Field Ablation (PFA) System in Treatment of Atrial Fibrillation
Table 74: Atrian Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 75: mPEF Device - Atrial Fibrillation - Product Status
Table 76: mPEF Device - Atrial Fibrillation - Product Description
Table 77: AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 78: AtriCure Bipolar System - Product Status
Table 79: AtriCure Bipolar System - Product Description
Table 80: AtriCure Isolator Synergy Surgical Ablation System - Inappropriate Sinus Tachycardia (IST) - Product Status
Table 81: AtriCure Isolator Synergy Surgical Ablation System - Inappropriate Sinus Tachycardia (IST) - Product Description
Table 82: AtriCure Inc - Ongoing Clinical Trials Overview
Table 83: AtriCure Bipolar System - Combined Endoscopic Epicardial and Percutaneous Endocardial Ablation Versus Repeated Catheter Ablation in Persistent and Longstanding Persistent Atrial Fibrillation
Table 84: Axon Therapies Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 85: Satera Ablation System - Product Status
Table 86: Satera Ablation System - Product Description
Table 87: Axon Therapies Inc - Ongoing Clinical Trials Overview
Table 88: Satera Ablation System - Endovascular Ablation of the Right Greater Splanchnic Nerve in Endovascular Ablation of the Right Greater Splanchnic Nerve in Subjects Having HFpEF: Feasibility Study: Randomized Controlled Feasibility Trial - Rebalance-HF Study
Table 89: Baylis Medical Company Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 90: Cardiac Ablation Mitigating Device - Product Status
Table 91: Cardiac Ablation Mitigating Device - Product Description
Table 92: Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 93: Omnypulse Bi-Directional Catheter - Product Status
Table 94: Omnypulse Bi-Directional Catheter - Product Description
Table 95: VARIPULSE Catheter - Product Status
Table 96: VARIPULSE Catheter - Product Description
Table 97: VARIPULSE Platform - Product Status
Table 98: VARIPULSE Platform - Product Description
Table 99: Biosense Webster Inc - Ongoing Clinical Trials Overview
Table 100: VARIPULSE Catheter - Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation with the BWI IRE Ablation System (AdmIRE)
Table 101: VARIPULSE Catheter - Versatility of a Circular Multielectrode Catheter in the Individualized Recognition & Treatment of Atrial Fibrillation and Related Arrhythmias Using Pulsed Field Energy
Table 102: Omnypulse Bi-Directional Catheter - Safety and Effectiveness Evaluation of the OMNYPULSE Catheter With the TRUPULSE Generator for Treatment of Paroxysmal Atrial Fibrillation (PAF)
Table 103: Corfigo Inc Pipeline Products & Ongoing Clinical Trials Overview 6
Table 104: HeArTPAD - Product Status 6
Table 105: HeArTPAD - Product Description 6
Table 106: Coridea, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 107: Cardiac Sympathetic Denervation Device - Product Status
Table 108: Cardiac Sympathetic Denervation Device - Product Description
Table 109: CPSI Biotech Pipeline Products & Ongoing Clinical Trials Overview
Table 110: ICEolate Catheter - Product Status
Table 111: ICEolate Catheter - Product Description
Table 112: ICEolate Catheter With Spot Ablation Tip - Product Status
Table 113: ICEolate Catheter With Spot Ablation Tip - Product Description
Table 114: ICEolate Surgical Probe With Control Handle - Product Status
Table 115: ICEolate Surgical Probe With Control Handle - Product Description
Table 116: ICEolate Surgical Probe With Flexible Ablation Tip - Product Status
Table 117: ICEolate Surgical Probe With Flexible Ablation Tip - Product Description
Table 118: Cryofocus Medtech Shanghai Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 119: Cryo-RDN System - Product Status
Table 120: Cryo-RDN System - Product Description
Table 121: Pulmonary Hypertension Cryoablation System - Product Status
Table 122: Pulmonary Hypertension Cryoablation System - Product Description
Table 123: CyberHeart Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 124: CyberHeart System - Product Status
Table 125: CyberHeart System - Product Description
Table 126: ElectroPhysiology Frontiers S.p.A. Pipeline Products & Ongoing Clinical Trials Overview
Table 127: Fiore Catheter - Product Status
Table 128: Fiore Catheter - Product Description
Table 129: Epiendoaf Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 130: EpiEndoAF Device - Product Status
Table 131: EpiEndoAF Device - Product Description
Table 132: Field Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 6
Table 133: FieldForce Ablation System - Product Status 6
Table 134: FieldForce Ablation System - Product Description 6
Table 135: Field Medical Inc - Ongoing Clinical Trials Overview 7
Table 136: FieldForce Ablation System - A Pre-Market, First-In-Human, Pilot, Interventional, Clinical Investigation to Evaluate Safety and Feasibility of the FieldForce™ Ablation System in Symptomatic Patients With Ventricular Arrhythmia 7
Table 137: Galaxy Medical Products Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 138: Centauri System - Product Status
Table 139: Centauri System - Product Description
Table 140: Galaxy Medical Products Inc - Ongoing Clinical Trials Overview
Table 141: Centauri System - Study Evaluating the Safety and Efficacy of the Centauri system (ECLIPSE-AF)
Table 142: Centauri System - Study Evaluating the Safety and Efficacy of the Centauri System in Patients with Persistent Atrial Fibrillation: SPACE-AF
Table 143: Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview
Table 144: Qualiblate - Product Status
Table 145: Qualiblate - Product Description
Table 146: Hangzhou Nuocheng Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 147: Liwen RF Ablation System - Product Status
Table 148: Liwen RF Ablation System - Product Description
Table 149: Hangzhou Nuocheng Medical Technology Co Ltd - Ongoing Clinical Trials Overview
Table 150: Liwen RF Ablation System - Confirmatory Clinical Study of Liwen RF Ablation System
Table 151: Hangzhou Nuomao Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 152: CardioPulse Field Ablation System - Product Status
Table 153: CardioPulse Field Ablation System - Product Description
Table 154: Hangzhou Nuomao Medical Technology Co Ltd - Ongoing Clinical Trials Overview
Table 155: CardioPulse Field Ablation System - An Exploratory Study of Focal Pulse Ablation System in the Treatment of Typical Atrial Flutter
Table 156: CardioPulse Field Ablation System - First in Man Study to Evaluate Safety and Efficacy of Left Atrial Appendage Pulsed Field Ablation Occluder for Simultaneous Pulsed Field Ablation and Mechanical Closure of the Left Atrial Appendage in Patients With Nonvalvular Atrial Fibrillation
Table 157: CardioPulse Field Ablation System - The Effectiveness and Safety of CardioPulse Pulse Ablation System in the Treatment of Paroxysmal Atrial Fibrillation
Table 158: Helical Solutions, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 6
Table 159: Catheter-Based Ablation Device - Product Status 6
Table 160: Catheter-Based Ablation Device - Product Description 6
Table 161: Huifeng Biotechnology (Shanghai) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 7
Table 162: Atrial Fibrillation Pulsed Field Ablation System - Product Status 7
Table 163: Atrial Fibrillation Pulsed Field Ablation System - Product Description 7

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings